$115.00
In stock
The NAD+/MOTS-c/5-amino-1MQ blend is an investigational synergistic formulation that combines direct NAD+ replenishment, the mitochondria-derived peptide MOTS-c (AMPK/glucose homeostasis activator), and the NNMT inhibitor 5-amino-1MQ
Store in a cool, dark place or freeze at -20°C for long term storage. Refrigerate after reconstitution
NAD+: 100MG
MOTS-c: 10MG
5amino 1MQ: 10MG
The NAD+/MOTS-c/5-amino-1MQ peptide blend represents a synergistic investigational formulation combining direct NAD+ replenishment (100 mg) MOTS-c (10 mg), a 16-amino-acid mitochondria-derived peptide (MRWQEMGYIFYPRKLR) encoded by mtDNA that translocates to the nucleus under metabolic stress to activate AMPK, and 5-amino-1MQ (10 mg), a small-molecule NNMT inhibitor that preserves endogenous NAD+ by blocking nicotinamide methylation, thereby elevating intracellular NAD+ and SAM levels
All items available on this website are intended exclusively for research and development purposes, including laboratory and analytical applications, and are not meant for human or animal consumption in any form. The products are not designed to diagnose, treat, cure, or prevent any medical conditions, and their associated claims have not been reviewed or approved by the U.S. Food and Drug Administration. Purus Peptides operates solely as a supplier of research chemicals and is neither a compounding pharmacy nor an outsourcing facility as defined by sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
Most products are sold in powder (lyophilized) form and require reconstitution with a suitable dilutant for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.
